Clinical Trials · NCT00414973
A Study for Patients With Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 364
- Start date
- Dec 2006
- Locations
- 5 sites, China
- Primary endpoint
- Percentage Change From Baseline to 24 Week Endpoint in Lumbar Spine Bone Mineral Density (BMD), Postmenopausal Women